Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Ferulic acid may help hair grow by activating certain receptors in cells.

SHBG binding properties are unchanged in male liver cirrhosis patients.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Alopecia patients have less GPER-1, which might affect hair loss.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

No link found between specific genes and female pattern hair loss.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Progesterone boosts alcohol's effect on brain, finasteride counters it.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.